Microvessel density is a prognostic indicator for patients with astroglial brain tumors

Cancer

Volumn 77, Issue 2, 1996, Pages 362-372

  Leon, Steven P ^a,b   Folkerth, Rebecca D ^a,b   Black, Peter McL ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

angiogenesis; brain nooplasm; factor VIII related antigen; glioma; immunohistochemistry; microvessel counts; multivariate analysis; prognosis; univariate analysis

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADULT; AGE FACTORS; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; ENDOTHELIUM, VASCULAR; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; VON WILLEBRAND FACTOR;

EID: 0030059969     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z     Document Type: Article

References (60)

1. Burger PC, Vogel S, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
2. Russell DS, Rubinstein LJ. Pathology of rumors of the nervous system. Baltimore: Williams and Wilkins, 1989.
3. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. 2nd Edition. Berlin: Springer-Verlag, 1993: 11-30.
4. Sheline GE. Radiation therapy of brain tumors. Cancer 1977;39:873-81.
5. Bloom HJG. Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980. Int J Radiat Oncol Biol Phys 1982;8:1083-1113.
6. Nelson DF, Diener-West M, Weinstein AS, Schoenfield D, Nelson JS, Sause WT, et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Int J Radiat Oncol Biol Phys 1986;12:1793-1800.
7. Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, et al. Hyperfractionated radiation therapy and bischlorethyl nitrosurea in the treatment of malignant glioma: possible advantage observed at 72.0 Gy in 1.2 B.I.D. fractions: report of the radiation therapy oncology group protocol 8302. Int J Radiat Oncol Biol Phys 1993;25:193-207.
8. Deutch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989;16:1389-96.
9. Winger MJ, Macdonald DR, Cairncross JG. Supratentorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 1989;71:487-93.
10. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group trials. J Natl Cancer Inst 1993;85:704-10.
11. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy and outcome. J Neurosurg 1993;78:767-75.
12. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 1986;10:611-17.
13. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MSB, Gutin PH, et al. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 1986;4:453-9.
14. Labrousse F, Daumas-Duport C, Batorski L, Hoshino T. Histologic grading and bromodeoxyuridine labeling index of astrocytomas: comparative study in a series of 60 cases. J Neurosurg 1991;75:202-5.
15. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 1993;53:550-5.
16. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns BJ, et al. Prognostic significance of Ki-67 proliferation index in Supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-9.
17. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972;175:409-416.
18. Hobson B, Denekamp J. Endothelial proliferation In tumors and normal tissues: continuous labelling studies. Br J Cancer 1984;49:405-13.
19. Findlay JK. Angiogenesis in reproductive tissues. J Endocrinol 1986;111:357-366.
20. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442.
21. Gimbrone MA, Leapman S, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-76.
22. Gimbrone MA, Cotran RS, Leapman S, Folkman J. Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 1974;52:413-27.
23. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
24. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
25. Weidner N, Semple JP, Welch WR, Folkman J. Tumor Angiogenesis and Metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
26. Larsen NS. Angiogenesis research yields new approaches to cancer treatment and prognosis. J Natl Cancer Inst 1993;85:1629-30.
27. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H, Sasse J. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 1988;48:2083-8.
28. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T, et al. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 1991;180:386-92.
29. Li V, Watanabe H, Yu C. Cerebrospinal fluid from pediatric brain tumor patients contains a mitogen for capillary endothelial cells. Mol Biol Cell 1992;3(Suppl):235a, 1360A.
30. Nguyen M, Watanabe H, Budson A, Richie JP, Hayes DF, Folkman J. Basic fibroblast growth factor is elevated in the urine of patients with a wide variety of neoplasms. Mol Biol Cell 1992;3(Suppl):234a, 1358A.
31. Watanabe H, Nguyen M, Schizer M, Li V, Hayes DF, Sallan S, et al. Basic fibroblast growth factor in human serum: a prognostic test for breast cancer. Mol Biol Cell 1992;3(Suppl):234a, 1359A.
32. Nguyen M, Watanabe H, Budson A, Richie JP, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of bladder cancer patients. J Natl Cancer Inst 1993;85:241-2.
33. Soutter AD, Nguyen M, Watanabe H, Folkman J. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 1993;53:5297-9.
34. Li VW, Folkerth RD, Watanabe H, Channing Y, Rupnick M, Barnes P, et al. Basic fibroblast growth factor in the cerebrospinal fluid of children with brain tumors - correlation with microvessel count in the tumor. Lancet 1994;344:82-6.
35. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988;133:419-23.
36. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
37. Horak E, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
38. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of nonsmall-cell lung cancer, Lancet 1992;340:145-6.
39. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
40. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-374.
41. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
42. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972;48:347-56.
43. Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 1976;23:440-53.
44. Brem H, Tamargo RJ, Guerin C, Brem SS, Brem H. Brain tumor angiogenesis. Mount Kisco: Futura Publishing Company, Inc., 1988:89-102.
45. Burger PC, Scheithauer BW, Vogel FS. Brain tumors. In surgical pathology of the nervous system and its coverings. 3rd edition. New York: Churchill Livingstone, 1991:193-437.
46. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152-65.
47. Pinkus GS, Etheridge CL, O'Connor EM. Are keratin proteins a better tumor marker than epithelial membrane antigen?: a comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. Am J Clin Pathol 1986;85:269-77.
48. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
49. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
50. Cox DR. Regression models and life-lables (with discussion). J Roy Soc Stat (B) 1972;34:187-220.
51. Peduzzi PN, Hardy RJ, Holford TR. A stepwise variable selection for nonlinear regression models. Biometrics 1980; 36:511-6.
52. Glantz MJ, Burger PC, Herndon II JE, Friedman AH, Cairncross JG, Vick NA, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-4.
53. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993;53:4161-3.
54. Feigen I, Allen LB, Lipkin L, Gross SW. The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation. Cancer 1958:11:264-77.
55. Haddad SF, Moore SA, Schelper RL, Goeken JA. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 1992;51:488-92.
56. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26.
57. Burger PC, Kleihues P, Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-23.
58. Paulus W, Peiffer J. Intratumoral histologic heterogeneity of gliomas. Cancer 1989;64:442-7.
59. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993;52:609-18.
60. Wesseling P, van der Laak AWM, De Leeww H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvascular in untreated human glioblastoma multiforme. J Neurosurg 1994;81:902-9.